None provided


The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Regulation of orexigenic AgRP neurons: A third way? Bingham NC, Cone RD (2015) Trends Endocrinol Metab 26(7): 339-40
    › Primary publication · 26033032 (PubMed)
  2. High calorie diet triggers hypothalamic angiopathy. Yi CX, Gericke M, Krüger M, Alkemade A, Kabra DG, Hanske S, Filosa J, Pfluger P, Bingham N, Woods SC, Herman J, Kalsbeek A, Baumann M, Lang R, Stern JE, Bechmann I, Tschöp MH (2012) Mol Metab 1(1-2): 95-100
    › Primary publication · 24024123 (PubMed) · PMC3757646 (PubMed Central)
  3. Bariatric surgery in hypothalamic obesity. Bingham NC, Rose SR, Inge TH (2012) Front Endocrinol (Lausanne) : 23
    › Primary publication · 22649412 (PubMed) · PMC3355900 (PubMed Central)
  4. Activation of the Hedgehog pathway in the mouse fetal ovary leads to ectopic appearance of fetal Leydig cells and female pseudohermaphroditism. Barsoum IB, Bingham NC, Parker KL, Jorgensen JS, Yao HH (2009) Dev Biol 329(1): 96-103
    › Primary publication · 19268447 (PubMed) · PMC2673990 (PubMed Central)
  5. Sex-specific roles of beta-catenin in mouse gonadal development. Liu CF, Bingham N, Parker K, Yao HH (2009) Hum Mol Genet 18(3): 405-17
    › Primary publication · 18981061 (PubMed) · PMC2638797 (PubMed Central)
  6. Targeted disruption of beta-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex. Kim AC, Reuter AL, Zubair M, Else T, Serecky K, Bingham NC, Lavery GG, Parker KL, Hammer GD (2008) Development 135(15): 2593-602
    › Primary publication · 18599507 (PubMed)
  7. Selective loss of leptin receptors in the ventromedial hypothalamic nucleus results in increased adiposity and a metabolic syndrome. Bingham NC, Anderson KK, Reuter AL, Stallings NR, Parker KL (2008) Endocrinology 149(5): 2138-48
    › Primary publication · 18258679 (PubMed) · PMC2329259 (PubMed Central)
  8. Fibroblast growth factor receptor 2 regulates proliferation and Sertoli differentiation during male sex determination. Kim Y, Bingham N, Sekido R, Parker KL, Lovell-Badge R, Capel B (2007) Proc Natl Acad Sci U S A 104(42): 16558-63
    › Primary publication · 17940049 (PubMed) · PMC2034251 (PubMed Central)
  9. A novel mutation in the accessory DNA-binding domain of human steroidogenic factor 1 causes XY gonadal dysgenesis without adrenal insufficiency. Reuter AL, Goji K, Bingham NC, Matsuo M, Parker KL (2007) Eur J Endocrinol 157(2): 233-8
    › Primary publication · 17656604 (PubMed)
  10. Development of a steroidogenic factor 1/Cre transgenic mouse line. Bingham NC, Verma-Kurvari S, Parada LF, Parker KL (2006) Genesis 44(9): 419-24
    › Primary publication · 16937416 (PubMed)
  11. Crystallographic identification and functional characterization of phospholipids as ligands for the orphan nuclear receptor steroidogenic factor-1. Li Y, Choi M, Cavey G, Daugherty J, Suino K, Kovach A, Bingham NC, Kliewer SA, Xu HE (2005) Mol Cell 17(4): 491-502
    › Primary publication · 15721253 (PubMed)
  12. A microdeletion in the ligand binding domain of human steroidogenic factor 1 causes XY sex reversal without adrenal insufficiency. Correa RV, Domenice S, Bingham NC, Billerbeck AE, Rainey WE, Parker KL, Mendonca BB (2004) J Clin Endocrinol Metab 89(4): 1767-72
    › Primary publication · 15070943 (PubMed)
  13. Molecular dynamics simulations of Trp side-chain conformational flexibility in the gramicidin A channel. Bingham NC, Smith NE, Cross TA, Busath DD (2003) Biopolymers 71(5): 593-600
    › Primary publication · 14635099 (PubMed)
  14. Noncontact dipole effects on channel permeation. I. Experiments with (5F-indole)Trp13 gramicidin A channels. Busath DD, Thulin CD, Hendershot RW, Phillips LR, Maughan P, Cole CD, Bingham NC, Morrison S, Baird LC, Hendershot RJ, Cotten M, Cross TA (1998) Biophys J 75(6): 2830-44
    › Primary publication · 9826605 (PubMed) · PMC1299956 (PubMed Central)